TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer-Reference-Cited by-同舟云学术

TORPEdO: A phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer

Published:2023-01 Issue: Volume:38 Page:147-154
ISSN:2405-6308
Container-title:Clinical and Translational Radiation Oncology
language:en
Short-container-title:Clinical and Translational Radiation Oncology

Author:

Thomson David J.,Cruickshank Clare,Baines Helen,Banner Russell,Beasley Matthew,Betts Guy,Bulbeck Helen,Charlwood Frances,Christian Judith,Clarke Matthew,Donnelly Olly,Foran Bernadette,Gillies Callum,Griffin Clare,Homer Jarrod J.,Langendijk Johannes A.,Lee Lip Wai,Lester James,Lowe Matthew,McPartlin Andrew,Miles Elizabeth,Nutting Christopher,Palaniappan Nachi,Prestwich Robin,Price James M.,Roberts Clare,Roe Justin,Shanmugasundaram Ramkumar,Simões Rita,Thompson Anna,West Catharine,Wilson Lorna,Wolstenholme Jane,Hall Emma

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference20 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J Clin,2021

2. Mehanna H, Evans M, Beasley M, Chatterjee S, Dilkes M, et al. Oropharyngeal cancer: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016 May;130(S2):S90-S96.

3. at al Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial;Nutting;Lancet Oncol,2011

4. TORPEdO - A Phase III Trial of Intensity-modulated Proton Beam Therapy Versus Intensity-modulated Radiotherapy for Multi-toxicity Reduction in Oropharyngeal Cancer;Price;Clin Oncol (R Coll Radiol),2020

5. National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group (CTRad) Proton Beam Clinical Trial Strategy Group. Proton Beam Therapy – the Challenges of Delivering High-quality Evidence of Clinical Benefit. Clin Oncol (R Coll Radiol). 2018 May;30(5):280-284.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute toxicities in proton therapy for head and neck cancer – A matched analysis of the DAHANCA 35 feasibility study;Clinical and Translational Radiation Oncology;2024-09

2. The timed 100 mL water swallow test for patients with head and neck cancer: What constitutes a clinically significant difference?;Head & Neck;2024-07-24

3. Proton beam radiotherapy head and neck cancer study design and endpoints;Radiotherapy and Oncology;2024-06

4. Impact of Relative Biologic Effectiveness for Proton Therapy for Head and Neck and Skull-Base Tumors: A Technical and Clinical Review;Cancers;2024-05-21

5. The National Radiotherapy Trials Quality Assurance Group – Driving up Quality in Clinical Research and Clinical Care;Clinical Oncology;2024-05